title: Inadvertent dexamethasone implant injection into the lens body management.
abstract: OBJECTIVE
  Dexamethasone intravitreal implant is an approved preparation in the treatment of macular edema. The most common adverse reactions are increased intraocular pressure and cataract but the inadvertent injection of the dexamethasone implant into the capsular bag is an extremely rare event.
  
  
  METHODS
  We present a case of a 78-year-old man treated for persistence of cystoid macular edema (CME) with Ozurdex intravitreal implant in which the procedure was complicated by the injection of the dexamethasone implant into the lens body and discuss the management.
  
  
  RESULTS
  The patient underwent phacoemulsification of the lens, replacement of the Ozurdex, and implant of a 3-piece lens in the posterior chamber.
  
  
  CONCLUSIONS
  The injection of an intravitreal dexamethasone implant (Ozurdex) into the lens body is an extremely rare complication that can be effectively and successfully managed with the surgical extraction of the implant from the lens body and implant of a 3-piece intraocular lens in the sulcus.
authors: West of England Eye Unit, RD&EH, Exeter - United Kingdom.
authors: Antonio
authors: A
authors: Berarducci
authors: Inderpaul S
authors: IS
authors: Sian
authors: Roland
authors: R
authors: Ling
mesh_terms: D000368:Aged; D020878:Device Removal; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D004343:Drug Implants / Q000009:adverse effects*; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007429:Intraocular Pressure; D019654:Lens Implantation, Intraocular; D007908:Lens, Crystalline / Q000187:drug effects*; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D018918:Phacoemulsification
chemical_list: D004343:Drug Implants; D005938:Glucocorticoids; D003907:Dexamethasone